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ABSTRACT 25 
In a previous study, it was shown that purified preS domains of hepatitis B virus (HBV) could 26 
interact with acidic phospholipid vesicles and induce aggregation, lipid mixing and leakage of 27 
internal contents which could be indicative of their involvement in the fusion of the viral and 28 
cellular membranes (Núñez, E. et al. 2009. Interaction of preS domains of hepatitis B virus with 29 
phospholipid vesicles. Biochim. Biophys. Acta 17884:417-424). In order to locate the region 30 
responsible for the fusogenic properties of preS, five mutant proteins have been obtained from 31 
the preS1 domain of HBV, in which 40 amino acids have been deleted from the sequence, with 32 
the starting point of each deletion moving  20 residues along the sequence. These proteins have 33 
been characterized by fluorescence and circular dichroism spectroscopy, establishing that, in all 34 
cases, they retain their mostly non-ordered conformation with a high percentage of β structure 35 
typical of the full-length protein. All the mutants can insert into the lipid matrix of 36 
dimyristoylphosphatidylglycerol vesicles. Moreover, we have studied the interaction of the 37 
proteins with acidic phospholipid vesicles and each one produces, to a greater or lesser extent, 38 
the effects of destabilizing vesicles observed with the full-length preS domain. The ability of all 39 
mutants, which cover the complete sequence of preS1, to destabilize the phospholipid bilayers 40 
points to a three-dimensional structure and/or distribution of amino acids rather than to a 41 
particular amino acid sequence as being responsible for the membrane fusion process. 42 
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Abbreviations 52 
HBV, Hepatitis B Virus; NBD-PE, N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-53 
dimyristoylphosphatidylethanolamine; Rh-PE, N-(lissamine rhodamine B sulfonyl)-54 
diacylphosphatidylethanolamine; DMPG, dimyristoylphosphatidylglycerol; ANTS, 8-55 
Aminonaphtalene-1,3,6-trisulfonic acid; DPX, p-xylenebis(pyridinium) bromide; NBD-F, 4-56 
fluoro-7-nitrobenz-2-oxa-1,3-diazole, IPTG, isopropyl-D-thiogalactopiranosyde; CCA, Convex 57 
Constraint Analysis. 58 
59 
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1. INTRODUCTION 60 
Hepatitis B virus (HBV) is a small DNA virus which infects the liver.  Although infection is 61 
usually followed by a complete recovery, in some cases the infection becomes chronic and may 62 
result in the development of cirrhosis and hepatocellular carcinoma. HBV infection is still a 63 
worldwide health problem despite the fact that an effective vaccine has been available for more 64 
than 25 years. About 240 million people are chronic carriers of HBV and about 1 million become 65 
infected yearly [1]. 66 
HBV envelope proteins are involved in the binding of the virus to the hepatocytes and in the 67 
cell entry mechanism [2]. There are three surface proteins designated as the small (S), medium 68 
(M) and large (L), that are the product of a single open reading frame. They share 226 amino 69 
acids (full-length S protein) at the C-terminus. The M protein has an extension of 55 amino 70 
acids, preS2, at the N-terminus of the S. The L protein is composed of the entire M protein and 71 
the preS1 region at the N-terminus which has 108-119 amino acids, depending on the HBV 72 
genotype. The regions preS1 and preS2 together are known as preS domains [3].  73 
The preS domains are functional at different steps of the virus life cycle. Several studies 74 
have demonstrated that preS1, and not preS2, contains the main hepatocyte specific binding 75 
domain [4], specifically a region from 21 to 47 residues [5-9]. Other studies indicate that the full-76 
length preS1 domain, with the exception of amino acids 78 to 87, is essential for the infectivity 77 
of HBV [10] and the species specificity has been attributed to the first 30 amino acids of preS1 78 
(subtype ayw) [11]. It is also widely accepted that myristoylation at Gly2 residue of the preS1 79 
domain plays an important role in specific binding to hepatocytes [3, 12-14]. Several molecules 80 
have been proposed to play a role in binding of HBV to hepatocytes [3, 15-17]. Very recently 81 
sodium taurocholate cotransporting polypeptide has been identified as a HBV cellular receptor 82 
[18].  83 
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Little is known about the involvement of the envelope proteins in the fusion between the 84 
viral and the host cell membrane. A peptide comprising the 16 amino acids at the N-terminal end 85 
of S protein have been shown to interact with model membranes, causing liposome 86 
destabilization in a pH-dependent manner and adopting an extended conformation during the 87 
process [19, 20]. Evidence for the role of the N-terminal S peptide in woodchuck hepatitis B 88 
virus (WHV) or duck hepatitis B virus (DHBV) infectivity has also been obtained by others 89 
researchers [21, 22]. On the other hand, we have previously shown that isolated preS domains 90 
(subtypes adw and ayw) are able to interact with acidic phospholipids vesicles and, as a result of 91 
this interaction, cause the destabilization of the bilayer, both at neutral and acidic pH [23]. 92 
Furthermore, the addition of this type of phospholipid vesicles led to a conformational change in 93 
the preS domain, increasing its helical content [23]. Similar results were obtained with the 94 
DHBV preS domain, despite the difference in the amino acid sequence [24]. Both domains share 95 
a similar hydrophobic profile, indicating that a three-dimensional conformation rather than a 96 
particular amino acid sequence would be responsible for the properties observed [24]. These 97 
results point to the possibility that both S and preS regions could contribute to the fusion of the 98 
viral and cellular membranes. Moreover, it has been shown that the preS2 domain plays an 99 
important role in virus assembly but it is dispensable in virus entry [25]. 100 
With the aim to locate the region of the preS domains responsible for the fusogenic 101 
properties, five deletion mutants along the preS1 sequence (subtype ayw) have been prepared. In 102 
each mutant, 40 amino acids were deleted, with the starting point of each deletion moving 20 103 
residues along the sequence. Thus, the mutants are designated preSΔ1-40, preSΔ20-60, preSΔ40-80, 104 
preSΔ60-100 and preSΔ80-120, indicating the deleted region in each case. All the proteins were 105 
characterized spectroscopically, and their interaction with phospholipids was studied. 106 
107 
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2. MATERIALS AND METHODS 108 
2.1 Enzymes and Reagents. Restriction enzymes, ligases, DNA polymerase and other molecular 109 
biology reagents were obtained from New England Biolabs, Promega, Invitrogen, Novagen or 110 
BRL. N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-dimyristoylphosphatidylethanolamine (NBD-PE), N-111 
(lissamine rhodamine B sulfonyl)-diacylphosphatidylethanolamine (Rh-PE) and 112 
dimyristoylphosphatidylglycerol (DMPG) were provided by Avanti Polar Lipids. 8-113 
Aminonaphtalene-1,3,6-trisulfonic acid (ANTS), p-xylenebis(pyridinium) bromide (DPX) and 4-114 
fluoro-7-nitrobenz-2-oxa-1,3-diazole (NBD-F) were purchased from Molecular Probes. Triton 115 
X-100 was obtained from Boehringer Mannheim. Sepharose CL-6B Ni-nitrilotriacetic acid 116 
(NTA) was purchased from Qiagen. All other reagents were obtained from Merck and Sigma. 117 
All solvents were of HPLC grade. 118 
 119 
2.2 Cloning of preS-his and preS1-40. To clone the preS domain (subtype ayw) and the preS1-120 
40 deletion mutant in the plasmid pT7-7 (Gibco BRL), the plasmid pET3d-preS-his-ayw [26], 121 
which contains the full-length preS domain (subtype ayw) followed by a region encoding a six-122 
histidines tag at the carboxy-terminal end, was used as template. The forward primers used were 123 
preS-NdeI(+): 5-'GGA GAT ATA  CAT  ATG GGG CAG AAT C and 1-40-NdeI(+): 5'C AAC 124 
AAG CAT ATG TGG CCA GAC GC; the reverse primer for both cloning was preS-HindIII(-) : 125 
5'-GCA GCC AAG CTT CTA CTA ATG GTG.  Underlined are the NdeI and HindIII restriction 126 
sites included in the primers.  127 
The PCR reaction conditions were: 1 min at 94 °C, followed by five cycles at 94, 60 and 72 128 
°C, each for 1 min, by 30 cycles at 94, 55 and 72 °C, each for 1 min, and a final “filling in” step 129 
at 72 °C for 7 min. The fragment of amplified DNA was purified by Wizard PCR Prep system 130 
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(Promega) and was subcloned into the linear plasmid pCR2.1 (Invitrogen), with 3'T ends and 131 
ampicillin resistance gene. pCR2.1-preS and pT7-7 plasmids were subsequently digested with 132 
restriction enzymes NdeI (Boehringer Mannheim, 10 U/μL) and HindIII (New England Biolabs, 133 
20 U/μL), in a final volume of 10 μL at room temperature for 16 h. After digestion, a 1% agarose 134 
gel was run. Once the suitable fragments had been copurified, using the QIAEX system 135 
(QIAGEN), they were ligated with bacteriophage T4 DNA ligase (Gibco BRL, 1 U/μL), at room 136 
temperature for 1-2 h, and E. coli DH5αF' cells were transformed with half of the reaction 137 
mixture. The positive colonies were identified by digestion of purified plasmid DNA with the 138 
restriction enzymes NdeI and HindIII. The individual cDNA sequences were confirmed by 139 
automated DNA sequencing. The resulting recombinant plasmids were called pT7-7-preS and 140 
pT7-7-1-40. 141 
 142 
2.3 Cloning of preS20-60, preS40-80, preS60-100 and preS80-120. The rest of the mutant cDNAs 143 
were obtained by the method described by Pogulis [27]. Briefly, the regions on both sides of the 144 
deletion were amplified separately by PCR, using the plasmid pT7-7-preS as template. Internal 145 
primers of each mutant had a complementary region of 18 nucleotides, corresponding to the 9 146 
final nucleotides and the first 9 nucleotides located before and after the deletion. The conditions 147 
of this first PCR reaction were the same as described above for preS and preS1-40. After running 148 
the PCR product on a 1.75% agarose gel and copurifying both regions using the QIAEX system 149 
(QIAGEN), a second elongation PCR using Taq Gold polymerase was carried out without 150 
primers in order to expand the area. The PCR conditions were: 15 cycles at 94, 52 and 72 °C, 151 
each for 1 min, followed by 7 min at 72 °C. 152 
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Finally, a third PCR using the amplified sequences as template, and the oligonucleotides 153 
preS-NdeI(+) and preS-HindIII(-) as primers, resulted in a DNA fragment with a region of 120 154 
nucleotides deleted and 3'A ends. The PCR conditions were: 32 cycles at 94, 55 and 72 °C, each 155 
for 1 min, followed by a final step of 7 min at 72 °C. Then, they were cloned into the pCR2.1 156 
plasmid, digested with restriction enzymes NdeI and HindIII and subsequently cloned into the 157 
plasmid pT7-7 digested with the same enzymes. The sequences of the different genes were 158 
confirmed by automated DNA sequencing. 159 
 160 
2.4 Expression and purification of preS-his and deletion mutants. pT7-7 recombinant 161 
plasmids with the preS-his domain or the different deletion mutants were used to transform E. 162 
coli HMS174 (DE3) cells. In all cases, the expression of the recombinant protein was under the 163 
control of the T-7 promoter, inducible by isopropyl-D-thiogalactopiranosyde (IPTG). 164 
A single colony was used to inoculate 50 mL of M9 medium supplemented with 0.17% 165 
glucose, 1.06 mM MgSO4, 0.053 mM CaCl2 and 100 µg/mL ampicillin. Following overnight 166 
incubation at 37 ºC, the culture was used to inoculate 950 mL of the same medium. This culture 167 
was grown to an optical density at 600 nm of 0.6 and the IPTG was added to a final 168 
concentration of 0.5 mM, and incubated at 37 °C for 4 hours to induce protein expression. Cells 169 
were harvested by centrifugation at 7400 g for 10 minutes in a GS-3 rotor (Sorvall). The cell 170 
pellet was resuspended in ice cold 10 mM MOPS pH 8.0, 10 mM imidazole, 0.3 M NaCl, 6 M 171 
Urea to avoid proteolytic degradation of proteins. Cells were lysed by sonication and centrifuged 172 
at 89500 g for 30 min in a Beckman SW-28 rotor. 173 
Recombinant proteins were purified using a single affinity chromatography step in 174 
Sepharose CL-6B Ni-nitrilotriacetic acid (NTA)-agarose column (Qiagen) equilibrated with 10 175 
mM MOPS pH 8.0, 10 mM imidazole, 0.3 M NaCl, 6 M Urea. After washing the non-176 
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specifically bound proteins with 10 mM MOPS pH 8.0, 30 mM imidazole, 6 M Urea, elution of 177 
the proteins was performed with 10 mM MOPS pH 8.0, 200 mM imidazole, 6 M Urea. The urea 178 
was removed by dialysis against 10 mM MOPS pH 7.0. The presence of the different proteins 179 
was monitored through the purification by SDS-PAGE. The amino acid composition and the 180 
protein concentration were determined on a Beckman 6300 automatic amino acid analyzer. 181 
 182 
2.5 Spectroscopic Characterization of preS-his proteins. The far-UV circular dichroism 183 
spectra were recorded on a Jasco J-715 spectropolarimeter equipped with a thermostated cell. 184 
The protein concentration was 0.1 mg/mL. The buffer used was 10 mM MOPS, pH 7.0 or pH 185 
5.0. A minimum of three spectra were accumulated for each sample and the contribution of the 186 
buffer was subtracted. Values of mean residue ellipticity were calculated on the basis of 110 as 187 
the average molecular mass per residue and they are reported in terms of [θ]M.R.W (degrees x cm2 188 
x dmol-1). The secondary structure of each protein was evaluated by computer fit of the 189 
dichroism spectra according to the algorithm convex constraint analysis (CCA) [28]. This 190 
method relies on an algorithm that calculates the contribution of the secondary structure elements 191 
that give rise to the original spectral curve without referring to spectra from model systems. 192 
Fluorescence studies were performed on a SLM Aminco 8000C spectrofluorimeter fitted 193 
with a 450 W Xenon lamp. The slits were set at 4 mm and the integration time was 1 sec. The 194 
protein concentration was always 0.05 mg/mL. The buffer used was 10 mm MOPS, pH 5.0 or 195 
7.0. At least three spectra were accumulated and the contribution of the buffer was subtracted. 196 
Excitation was performed at a wavelength of 275 or 295 nm, and emission spectra measured over 197 
a range of 285-465 nm. The tyrosine contribution to the emission spectra was calculated by 198 
subtracting from the emission spectra measured at λexc = 275 nm the emission spectra measured 199 
at λexc = 295 nm multiplied by a factor that was obtained from the ratio between the fluorescence 200 
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intensities measured with λexc = 275 nm and λexc = 295 nm at wavelengths higher than 380 nm, 201 
where there is no tyrosine contribution. 202 
 203 
2.6 Labeling of preS-his proteins. Fluorescent labeling of the N-terminus of the protein was 204 
achieved by the procedure of Rapaport and Shai [29] as previously described [24]. Some NBD-205 
labeled proteins precipitated in the column. In these cases, the protein was denatured with 6 M 206 
Urea. The denaturant and the excess label reagent were removed by exhaustive dialysis against 207 
10 mM MOPS pH 5.0 or 7.0, with decreasing concentrations (1, 0.5, 0.2, 0.1 and 0 M) of Urea. 208 
 209 
2.7 Vesicle preparation. The vesicles used were prepared by sonication and extrusion in a 210 
Liposo Fast-Basic extruder apparatus (Avestin, Inc.) with 100-nm polycarbonate filters (Costar) 211 
as previously described [24].  212 
 213 
2.8 Binding assay. The binding of NBD-preS-his or NBD-mutant proteins to PG vesicles was 214 
studied as previously described [24]. Briefly, after incubation of the protein (0.03-0.06 μM) with 215 
the vesicles for 1-2 min, the fluorescence spectra were taken between 480 and 650 nm with the 216 
excitation wavelength set at 467 nm in a SLM AMINCO 8000C spectrofluorimeter (SLM 217 
Instruments). The fluorescence intensity registered at 530 nm at different lipid/protein molar 218 
ratios was utilized to obtain the binding isotherm. The data were analysed using the equation: 219 
 220 
Xb*= Kp*·Cf  221 
 222 
where Xb* is the molar ratio of bound protein per total lipid corrected taking into account that 223 
proteins only partitioned over the outer leaflet of vesicles (Xb*=Xb / 0.6), Kp* corresponds to the 224 
 11
corrected partition coefficient and Cf represents the equilibrium concentration of free protein in 225 
solution. At every phospholipid concentration, the fraction of bound protein can be calculated by 226 
the formula: 227 
 228 
fb = (F− F0)/(F∞−F0)  229 
 230 
where F0 represents the fluorescence of unbound protein and F∞ the fluorescence of bound 231 
protein. In all cases, fluorescence from control vesicles in the absence of labeled protein was 232 
subtracted. At least three different experiments were performed for each condition. 233 
 234 
2.9 Vesicle aggregation. The aggregation of phospholipid vesicles induced by the addition of 235 
preS-his and mutant proteins was followed by measuring the optical density at 360 nm (OD360) 236 
on a Beckman DU-7 spectrophotometer [24]. The final phospholipid concentration was kept at 237 
60 µM. At least three different experiments were performed for each condition.  238 
 239 
2.10 Lipid mixing. The fluorescent probe dilution assay [30] was employed to determine lipid 240 
mixing. All the conditions are coincident with those previously used for human and duck preS 241 
proteins [23]. The energy transfer efficiency was calculated from the ratio of the emission 242 
intensities at 530 and 590 nm and the appropriated calibration curve.  243 
 244 
2.11 Release of aqueous contents. The integrity of the phospholipid vesicles was assessed by 245 
the ANTS/DPX leakage assay [31] as previously described [23]. ANTS and DPX were co-246 
encapsulated in phospholipid vesicles at 12.5 mM and 45 mM respectively, in 10 mM Tris pH 247 
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7.2, 20 mM NaCl. The non-encapsulated material was eliminated by chromatography in a 248 
Sephadex G-75 column (Pharmacia). The phospholipid concentration was kept at 0.1–0.14 mM. 249 
The fluorescence spectra were measured in a SLM Aminco 8000C spectrofluorimeter. The 250 
excitation wavelength was set at 385 nm and the ANTS emission was monitored at 520 nm. The 251 
fluorescence of control vesicles without protein was taken as 0% leakage while 100% was 252 
considered upon addition of 0.5% Triton X-100.  253 
254 
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RESULTS 255 
3.1 Expression and purification. After inducing the expression of the preS and mutants with 256 
IPTG, the recombinant proteins were purified as described in the Experimental procedures 257 
section. The results of the purification steps of preS-his are shown in Figure 1A as an example. 258 
Induction with IPTG resulted in the appearance of a band which corresponded to the molecular 259 
mass of the preS-his domain (Fig. 1A, lanes 2 and 3). After lysis of the cells all the protein 260 
remained soluble (Fig. 1A, lane 5). Moreover, when loaded onto the Ni-NTA column most of the 261 
protein was retained (Fig. 1A, lane 6). The proteins were eluted with 10 mM MOPS pH 8.0, 200 262 
mM imidazole, 0.3 M NaCl, 6 M urea. All proteins were homogeneous as it is shown by SDS-263 
PAGE (Fig. 1B), with an electrophoretic mobility corresponding to that expected according to 264 
their molecular mass (Table 1), except for preS 40-80, which has a lower mobility (Fig. 1B, lane 265 
5). Moreover, their purity was higher than 98% in every case. Under these conditions, 15 mg per 266 
liter of cell culture of preS-his and about 3-6 mg of the different mutants were obtained. 267 
The amino acid composition of the purified proteins was practically coincident with that 268 
expected from the cDNA sequence (Table 2), indicating the purity of the sample. The most 269 
significant difference between experimental and theoretical values was the number of methionine 270 
residues. In all cases, except for the mutant preS1-40, after acid hydrolysis the methionine 271 
content was one residue lower than expected. It is likely that the amino-terminal methionine had 272 
been removed by the action of the E. coli methionyl amino peptidase except for the mutant 273 
preS1-40 where the peptidase seems not to be able to hydrolyze the corresponding Met-Trp 274 
peptide bond [32]. 275 
 276 
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3.2 Spectroscopic characterization. The preS domain (subtype ayw) has four tryptophan 277 
residues (W32, W41, W66 and W111) and one tyrosine (Y129). Therefore, all deletion mutants 278 
will have the tyrosine residue, while the tryptophan content will depend on the deleted sequence, 279 
being this number between 2 and 3. Figure 2 shows the fluorescence emission spectra of preS-his 280 
and the different mutant proteins at pH 7.0 which are very similar to those obtained at pH 5.0. 281 
The fluorescence emission maximum is centered at 344 nm, regardless of the excitation 282 
wavelength, which indicates that the tryptophan residues are found in a relatively polar 283 
environment. The contribution of the tyrosine residue to the fluorescence emission is very small, 284 
negligible in some cases. This may reflect the lower absorptivity and quantum yield of Tyr 285 
compared to Trp although it could also be due to a process of resonance energy transfer from Tyr 286 
to the nearby Trp residues or to fluorescence quenching of its neighboring residues in the three 287 
dimensional structure of the protein. Nevertheless, the fluorescence intensity at the maximum 288 
reflects the lower tryptophan content of mutants preS20-60 and preS40-80. 289 
The far-UV CD spectra of preS-his at pH 7.0 and 5.0 are depicted in Figure 3A. The shape 290 
of the spectra, with a minimum at 200 nm and a shoulder at 220 nm, is indicative of a protein 291 
with a high percentage of non-ordered structure. Figure 3B shows the spectra of the mutant 292 
proteins at pH 7.0 that are very similar to those recorded at pH 5.0 in all cases. The assignment 293 
of the secondary structure elements according to the algorithm CCA [28] is presented in Table 3. 294 
Regardless of pH, the major repetitive ordered secondary structure component is β-sheet (9 to 295 
21%, depending of the mutant protein) and, approximately, a third of the amino acids are in β-296 
turn. It should be noted that 48-59 % of the protein has an aperiodic secondary structure and that 297 
helical structure is not present. 298 
  299 
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3.3 Interaction with phospholipids. The interaction of native and mutant preS domains with 300 
phospholipids was studied using two approaches. Firstly, the proteins were labeled with NBD-F. 301 
Fluorescent labelling of mutant proteins other than preS1-40 resulted in a precipitated sample. 302 
Hence, the labeled proteins were denatured with 6 M urea, and then the denaturant agent was 303 
removed by exhaustive dialysis against 10 mM MOPS pH 5.0 or 7.0. The far-UV CD spectra of 304 
NBD-labeled preS polypeptides were coincident with those of the unlabeled ones. The extent of 305 
labelling was calculated from the absorbance spectrum. It was found that all the proteins were 306 
labeled approximately in a 1:1 (NBD: protein) ratio. Considering that the reaction was carried 307 
out at pH 6.8, it is expected that the α-amino group, and not the Lys side chain, be the main 308 
labelling target [33]. 309 
It has been previously shown that the interaction of NBD-preS-his protein with neutral 310 
phospholipid vesicles is very weak and the binding constant cannot be determined from this type 311 
of experiment [23]. Thus, PG vesicles were used to compare the interaction of the mutant 312 
proteins with phospholipids. In the absence of phospholipid vesicles, the emission maximum of 313 
NBD-labeled proteins was centered at 546 nm, a value similar to that described for other NBD 314 
derivatives [29]. Upon interaction with PG vesicles at pH 5.0, the fluorescence intensity 315 
increased considerably and the emission maximum was shifted to 522-528 nm (Fig. 4), 316 
indicating that the fluorescent probe has been relocated to a more hydrophobic environment. At 317 
pH 7.0, the emission maximum shifted to 532 nm and the increase in fluorescence intensity was 318 
considerably lower (data not shown). From the fluorescence intensity values observed at pH 5.0 319 
the binding isotherms were plotted (Fig. 5). In the case of the wild-type protein and mutants 320 
preS1-40 and preS60-100 two different slopes were observed (Fig. 5A, B, E). This behavior has 321 
been associated with protein aggregation upon binding to the membrane and the formation of 322 
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large pores in the vesicles [34]. However, the mutants preS40-80 and preS80-120 only have one 323 
slope in the binding isotherms (Fig. 5D, F) and preS20-60 mutant presented a very small 324 
difference between the two slopes (Fig. 5C). The partition coefficients, reflecting the binding 325 
constants, were calculated as the initial slopes of these binding isotherms (Table 4). In the 326 
presence of acidic phospholipids and at pH 5.0, a value between 1.4 and 2.9 x 104 M-1 was 327 
obtained for all recombinants proteins. 328 
Secondly, circular dichroism was used to ascertain the structural changes which occur in the 329 
proteins as the result of their interaction with phospholipid vesicles. The spectra obtained with 330 
both preS-his and the different mutants in the presence of PG vesicles are shown in Figure 6. At 331 
pH 5.0 the behavior was very similar for all proteins. Thus, low concentrations of phospholipid 332 
(protein:lipid molar ratio of 1:5) produced an increase in ellipticity values, which could be due to 333 
aggregation of the proteins on the surface of the bilayer resulting in a lower effective protein 334 
concentration. This effect is more pronounced in the case of preS60-100 and preS80-120 (Fig. 6, 335 
pH 5.0, E-F). Since these two mutants have the lowest isoelectric point of all the recombinant 336 
proteins, they would have a lower positive charge that would enable them to interact and form 337 
aggregates in a higher proportion. When the phospholipid concentration was increased, 338 
protein:lipid molar ratio of 1:20, a shift from 200 nm to 210 nm and the appearance of a shoulder 339 
at 225 nm were observed, indicating a conformational change to a secondary structure with a 340 
higher content in helical structures. When the concentration of phospholipid was increased to a 341 
protein:lipid molar ratio of 1:50, the helical conformation was maintained resulting in a spectrum 342 
similar in shape to that observed at a 1:20 molar ratio but with lower ellipticity values, probably 343 
due to the presence of a higher proportion of protein in monomeric form. At pH 7.0, the 344 
differences between the spectra obtained at 1:20 and 1:50 practically disappeared. As it can be 345 
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seen in Table 5, where the percentages of the different secondary elements at a protein:lipid 346 
molar ratio of 1:50 are shown, although the percentage of non-ordered structure was still high, 347 
the percentages of α-helix (14-23%) and β-sheet (16-40%) increased considerably at the expense 348 
of β-turn. At pH 7.0, and except for the preS1-40 mutant, an increase in α-helix concomitant with 349 
a decrease in the percentage of extended structure in all cases was observed. 350 
 351 
3.4 Vesicles destabilization. The HBV preS domains have been shown to have membrane 352 
destabilization properties [23], including the ability to cause vesicle aggregation, lipid mixing 353 
and release of aqueous contents. The capability of the deletion mutants to retain these properties 354 
was also examined.   Vesicle aggregation was followed by measuring the variation of the optical 355 
density at 360 nm (ΔOD360) after incubation of PG vesicles at a concentration of 60 M with 356 
different concentrations of protein at 37 °C for 1h. At pH 7.0, the highest increase in optical 357 
density occurs with the wild type protein and preS20-60, whereas preS1-40, preS40-80 and preS60-358 
100 produced a lower increase and preS80-120 was not able to induce aggregation (Fig. 7A). 359 
However, at pH 5.0 the ΔOD360 increased in a concentration dependent manner reaching a 360 
maximum at 5.5 μM in all cases (Fig. 7A).  361 
Lipid mixing of phospholipid vesicles was followed by the resonance energy transfer (RET) 362 
assay between the fluorescence probes NBD-PE and Rh-PE incorporated into a lipid matrix in 363 
which mixing of phospholipids from labeled and unlabeled liposomes resulted in a decrease in 364 
energy transfer [30]. Native preS as well as the mutants were able to induce lipid mixing at pH 365 
7.0, although the decrease in energy transfer induced by preS100-120 was higher at lower 366 
concentrations of protein (Figure 7B). The % RET decreased from 65% in the absence of 367 
protein, up to 6.5% for a final protein concentration of 8 M. These values correspond to a 10-368 
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fold dilution in the acceptor surface density, indicating that the complete fusion of vesicles has 369 
been induced, since the mere aggregation would not account for this decrease in energy transfer 370 
[35]. The same final effect was observed for preS-his and preS40-80 and preS60-100 mutants, 371 
reaching in all cases the complete fusion of the vesicles. In the case of preS1-40 and preS20-60, 372 
the % RET only decreases to 29 and 15% respectively (Fig. 7B), probably because vesicle 373 
aggregation prevailed over fusion. At pH 5.0 there were no major differences between proteins, 374 
leading to a decrease in the % RET to 10 % in all cases, which implies the complete fusion of 375 
vesicles (Fig. 7B). 376 
The increase in permeability induced by the addition of preS domain and mutant proteins 377 
has been studied according to the assay described by Ellens [31]. As described above for 378 
aggregation and lipid mixing, the release of aqueous contents is also a protein concentration-379 
dependent process although the maximum effect at pH 7.0 was reached at a protein concentration 380 
(0.25-2.0 M) much lower than that needed to achieve the maximum effect in the other assays 381 
(5-8 M) (Fig. 7C). For the mutant preS1-40, the maximum effect was reached at the lowest 382 
protein concentration (0.2 M), whereas preS40-80 and preS80-120 required a concentration 10 383 
times higher, 2 µM (Fig. 7C). The maximum fluorescence value reached (85-99%) was similar to 384 
that described for other proteins but lower than the value obtained after the addition of Triton X-385 
100 (100%). At pH 5.0 the behavior of all proteins was nearly identical and in all cases a lower 386 
protein concentration is needed to attain the same effect observed at pH 7.0 (Fig. 7C). 387 
388 
 19
3. DISCUSSION 389 
We have previously suggested that different regions of the surface proteins of HBV may be 390 
involved in the fusion of viral and cellular membranes [23]. Specifically, the N-terminal portion 391 
of the S protein and the preS domains were proposed to contribute at the fusion process either 392 
simultaneously or at different stages. To gain information on the location of the region(s) 393 
responsible for the destabilizing properties of preS domain we have cloned and purified the preS 394 
domain (subtype ayw) and five deletion mutants where a region of 40 amino acids of the preS1 395 
region has been consecutively removed along the sequence of preS (preS1-40, preS20-60, preS40-396 
80, preS60-100 and preS80-120). About 15 mg of wild-type protein and 3-6 mg of highly pure 397 
mutated protein per liter of culture medium have been obtained. 398 
The spectroscopic characterization of preS domain and deletion mutants was carried out by 399 
means of circular dichroism and fluorescence spectroscopy. PreS domain possesses a high 400 
percentage of non ordered structure with the different secondary structure elements arranged in 401 
an open conformation [26, 36, 37]. Deconvolution of far-UV circular dichroism spectra shows 402 
that the secondary structure of the mutant proteins does not vary significantly with respect to that 403 
of the native protein. 48-59% of the residues are in non-regular structure, while β-sheet is the 404 
major ordered repetitive structure (9-21%). 405 
PreS domains have the ability to interact with phospholipid vesicles, as indicated by the 406 
changes that the fluorescence spectrum of NBD-labeled protein undergoes when challenged by 407 
phospholipids [23]. Since the highest effect was observed with acidic phospholipids at pH 5.0, 408 
the experiments with the truncated forms were carried out under these conditions. In the presence 409 
of PG vesicles at pH 5.0, the fluorescence emission maximum of NBD shifts from 546 to 526-410 
528 nm in all cases. This change reflects a relocation of NBD into a more hydrophobic 411 
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environment and is comparable to that obtained for peptides which are known to insert deeply 412 
into the bilayer [29, 34, 38, 39]. Furthermore, binding isotherms, derived from the increments in 413 
fluorescence intensities, provide information about the way in which the interaction occurs [40, 414 
41]. The two slopes which are observed in all cases, except preS40-80 and preS80-120, are 415 
indicative of a high tendency to interact with the lipid bilayer and to form aggregates and pores 416 
[34]. The shape of the binding isotherm obtained for preS40-80 and preS80-120, with a single 417 
slope, could indicate that, at the concentration range studied, the interaction of these mutants 418 
occurs in a monomeric form originating small pores. Therefore, it seems that some of the amino 419 
acids deleted in these two mutants are necessary for the oligomerization to take place. The 420 
partition coefficients, which reflect the binding constant, were calculated from the initial slope of 421 
the binding isotherm, resulting in all cases a value of the order of 104 M-1, similar to that 422 
previously obtained for preS (subtype adw) [23] and duck hepatitis B virus preS domains [24]. 423 
They are also very similar to those described in the case of peptides that strongly interact with 424 
the bilayer, as is the case of peptides corresponding to the HA protein of influenza virus [42], the 425 
internal peptide of Sendai virus [39] and peptides able to form pores therein [29, 38].  426 
Interaction with liposomes also established structural alterations in the preS domains and 427 
mutant proteins. CD spectra obtained in the presence of acidic phospholipid vesicles show that at 428 
low concentrations of phospholipid the value of the molar ellipticity increases in all cases, more 429 
at pH 7.0 and at pH 5.0 for preS60-100 and preS80-120. Under these conditions, and given the low 430 
lipid concentration, an increase in the surface density of proteins in the bilayer could favour its 431 
aggregation and hence, a higher local concentration of chromophores which could promote a 432 
decrease in absorption [43, 44]. This aggregation effect is transient because when the 433 
concentration of phospholipid increases a reduction in the ellipticity values is noticed. In this 434 
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regard, it was found that the carboxy- and amino-terminal heptad region of the fusion protein of 435 
Sendai virus form complexes in solution [45] which then dissociate into monomers when they 436 
bind to the membranes [46]. A similar effect has been described for HIV [47]). As a result of the 437 
interaction with acidic phospholipids, from a protein:lipid molar ratio of 1:20 and both at pH 7.0 438 
and 5.0, there is a conformational change of the protein that resulted in an increase of the 439 
percentage of helical content, that is very similar in all cases, except for preS80-120 mutant at pH 440 
7.0, which retain a high content of non-ordered structures. As indicated above, the results 441 
obtained with the domains labeled with NBD point to the insertion of the amino-terminal end of 442 
the protein into the bilayer. In this sense, myristoylation of the Gly2 residue of the preS domain 443 
[3] would help this region to insert. Thus, it seems reasonable to think that the conformational 444 
transition to a helical structure occurs in this area, remaining the rest of the protein at the polar 445 
surface, maintaining its original structure. As it has been reported in other fusogenic viral 446 
proteins, such as the hemagglutinin influenza virus [48, 49] or the vesicular stomatitis virus [50], 447 
preS domains not only interact with but also are able to destabilize model membrane systems. 448 
Both native and mutant proteins have destabilizing properties (aggregation, lipid mixing and 449 
release of aqueous contents) in a pH-dependent manner, with the effects observed at pH 5.0 450 
higher than those obtained at neutral pH, especially at low protein concentration. Aggregation 451 
results at pH 7.0 are those which provide greater differences between the recombinant proteins. 452 
According to these results, the region 20-60 is completely dispensable since the mutant preS20-60 453 
gives comparable results to those obtained with full length preS domain. Similarly, the 1-40 454 
region seems not to have any involvement in the interactions that promote vesicle aggregation. 455 
However, any of the other areas that are missing in the other three mutants would be required for 456 
the establishment of such interactions, especially the regions 40-80 and 80-120. The differences 457 
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could be explained on the basis of the net charge of the protein at pH 7.0. The mutants preS60-100 458 
and preS80-120 that have a similar isoelectric point, 6.78 and 6.41 respectively (Table 1) would 459 
have the same behavior. However, preS80-120 is not able to induce aggregation, while preS60-100 460 
induces vesicle aggregation to the same level than the mutant preS1-40, which is the one with the 461 
highest positive charge at neutral pH (pI 11.34). It is therefore clear that ionic interactions are 462 
important in determining the aggregation but there must be some additional factors which are 463 
also important. As indicated above by the results of the interaction studies with NBD-labeled 464 
proteins, preS40-80 and preS80-120 are the mutants that interact with lipid bilayers in a 465 
monomeric way. The rest of mutants and the wild type protein induce aggregates that can give 466 
rise to an extensive network of vesicles, interacting among themselves, that would account for 467 
the increase in optical density at 360 nm. The fact that preS60-100 can form oligomers and induce 468 
aggregation, like the rest of mutants, is indicative that the regions responsible for this effect are 469 
located between amino acids 40-60 and 100-120. 470 
The inability of mutant preS40-80 and preS80-120 to form aggregates upon interaction with 471 
phospholipids could explain their reduced ability to induce release of aqueous contents, since the 472 
absence of such complexes has been also related to the formation of smaller pores on the 473 
membrane [29]. On the other hand, interaction in a monomeric way may also facilitate the 474 
diffusion of NBD-PE and Rh-PE molecules in the fused vesicles, allowing the preS80-120 mutant 475 
to induce lipid mixing more efficiently. In contrast, preS1-40 and preS20-60, with a greater 476 
capacity to form protein aggregates on the bilayer, are those that produce the greatest vesicle 477 
aggregation and release of aqueous contents. In this regard, it has been postulated that 478 
oligomerization is necessary for the oblique insertion of fusogenic peptides in the membrane, a 479 
condition which strongly promotes fusion [51-53]. 480 
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Special attention must be paid to the results obtained with mutants preS1-40 and preS20-60. 481 
These proteins have a greater ability to destabilize lipid vesicles, both at pH 7.0 and pH 5.0 and 482 
at lower protein concentration, than the wild type protein. This could indicate that the first 60 483 
amino acids are not required to initiate the fusion process. This region has been related to the 484 
interaction with the receptor and to the species specificity [3, 13]. In addition, the region between 485 
amino acids 47-67 is the most hydrophobic of the preS domain with a hydrophobicity index of 486 
0.7 (Fig. 8), and could be responsible for the insertion of the preS domain in lipid bilayer. 487 
Indeed, it possesses the characteristic of a transmembrane helix and also the Gly-X-Phe sequence 488 
characteristic of fusogenic peptides, present in the influenza virus and in a reversed form at the 489 
amino-terminal of the fusogenic peptide of paramyxovirus, in the center of retrovirus and S 490 
domain of HBV [54]. It is also a highly conserved domain among the different HBV subtypes 491 
(Fig. 9A) and has sequence homology with fusogenic peptides of viruses such as HIV (Fig. 9B). 492 
However, as noted above, this area does not appear to be necessary in the mutants to destabilize 493 
lipid vesicles.  494 
All the differences between the mutant proteins disappear at acidic pH and high protein 495 
concentration. This could be related to the higher positive charge of all the mutants at lower pH. 496 
Anyway, it is clear that all of the mutants, to a greater or lesser extent, may interact with acidic 497 
phospholipid and display all the properties assigned to fusogenic proteins. These data would 498 
indicate that there is no a specific region of the protein responsible for the fusion of viral and 499 
cellular membranes. Like other viruses, such as paramyxoviruses, where there are no sequence 500 
homologies between them [55, 56], it is the tridimensional structure of the fusogenic peptides 501 
what determines the ability to destabilize vesicles and not the amino acid sequence [57, 58]. In 502 
this regard, the CD spectra indicate that both the full-length protein and the mutants have a 503 
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similar secondary structure. Moreover, the hydrophobicity profiles indicate that all the proteins 504 
share a similar distribution of polar and nonpolar amino acids (Fig. 8). Since all proteins used in 505 
this study share the carboxyl-terminal region, which corresponds to the preS2 domain, this area 506 
could be responsible for the ionic interaction with the polar head of the phospholipids. Then, the 507 
preS1 domain could insert into the bilayer causing its destabilization due to the fact that there is a 508 
particular three dimensional structure and/or a distribution of specific amino acids.  509 
We have previously proposed that both the N-terminal region of the S protein as well as the 510 
preS domains may be involved in the initial steps of viral infection [23].Thus, antibodies elicited 511 
against both regions may play an important role in controlling the infection. Although this study 512 
shows that the first 60 amino acids of preS do not seem to be involved in the interaction and 513 
destabilization of lipid bilayers, and since it has been shown that this region is important for the 514 
infectivity [3] the use of full-length preS domains as part of a vaccine against HBV infection 515 
seems appropriate. In fact, it has been reported an increase in antibody response to a vaccine 516 
containing both preS1 and preS2 even in a population that include low responders to the 517 
conventional vaccine [59]. Also, there is a phase II clinical trials in chronic HBV-infected 518 
patients with a vaccine including preS-derived peptides [2]. 519 
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FIGURE LEGENDS 
 
FIG 1. SDS-PAGE of preS-his and deletion mutants purification steps. (A) The purification 
steps of preS-his are shown as an example: (1) Protein markers; (2) Non induced cells; (3) Cells 
induced with IPTG for 4 h; (4) Pellet from cell lysate; (5) Supernatant from cell lysate; (6) 
Protein non retained in the Ni-NTA column. (B) Protein eluted from the column with 10 mM 
MOPS pH 8.0, 200 mM imidazole. (1) Protein markers; (2) preS-his; (3) preS1-40; (4) preS20-60; 
(5) preS40-80; (6) preS60-100; (7) preS80-120. The gel was stained with Coomassie blue. 
 
FIG 2. Fluorescence emission spectra of preS-his (A), preS1-40 (B), preS20-60 (C), preS40-80 
(D), preS60-100 (E) and preS80-120 (F) at pH 7.0. The spectra were obtained upon excitation at 
275 nm () and 295 nm (- -). The contribution of tyrosine residues to the emission spectra of the 
protein (·····) was calculated as described in the Experimental procedures section. Protein 
concentration was 0.07 mg /mL. The buffer used was 10 mM MOPS pH 7.0. The results shown 
are representative of those obtained for three different experiments. 
 
FIG 3. Circular dichroism spectra of preS-his and mutant proteins. (A) preS-his at pH 5.0 () 
and 7.0 (- - -).  (B) Mutants proteins at pH 7.0, preS1-40 (), preS20-60 (■), preS40-80 (□), 
preS60-100 (▲) and preS80-120 (∆). Protein concentration was 5 μM and cell path length 0.1 cm. 
The buffer employed was 10 mM MOPS at the appropriate pH. The results shown are 
representative of those obtained for three different experiments. 
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FIG 4. Fluorescence spectra of NBD-preS-his (A), NBD-preS1-40 (B), NBD-preS20-60 (C), 
NBD-preS40-80 (D), NBD-preS60-100 (E) and NBD-preS80-120 (F). Spectra were measured with 
an excitation wavelength of 467 nm. The protein concentration used was 0.15-0.20 μM. The 
spectra of the proteins in the absence (- - -) and presence (—) of lipids at a lipid:protein molar 
ratio of 5000:1 after incubation of the protein with PG vesicles in medium buffer at pH 5.0 are 
shown. The results shown are representative of those obtained for three different experiments. 
 
FIG 5. Binding isotherm of NBD-preS-his (A), NBD-preS1-40 (B), NBD-preS20-60 (C), NBD-
preS40-80 (D), NBD-preS60-100 (E) and NBD-preS80-120 (F) to PG vesicles at pH 5.0. Values of 
Xb* and Cf are calculated from the increments in fluorescence intensity at 530 nm as described in 
the Experimental procedures section. Insets represent the initial slope of the corresponding 
binding isotherm used to calculate the partition coefficients. The results shown are representative 
of those obtained for three different experiments. 
 
FIG 6. CD spectra of preS-his (A) and preS1-40 (B), preS20-60 (C), preS40-80 (D), preS60-100 (E) 
and preS80-120 (F) in the presence of PG. The spectra were measured after incubation of the 
protein in 10 mM MOPS pH 5.0 or 7.0 with different concentrations of the phospholipid for 1 h 
at 37 °C. The protein concentration was 5 M. Protein in solution () and protein in the presence 
of PG at a protein:lipid molar ratio of 1:5 (), 1:20 (▲) and 1:50 (∆).The results shown are 
representative of those obtained for three different experiments. 
 
FIG 7. Aggregation (A), lipid mixing (B) and leakage (C) of PG vesicles induced at pH 7.0 and 
5.0 by preS-his (), preS1-40 (), preS20-60 (■), preS40-80 (□), preS60-100 (▲) and preS80-120 (∆). 
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The final phospholipid concentration was 60 µM (A) and 0.14 mM (B and C). The results shown 
are representative of those obtained for at least three different experiments. (A) The increase in 
optical density at 360 nm (ΔOD360) was measured after incubation of the vesicles with the 
proteins at different concentrations. Values of control samples containing only PG liposomes 
were subtracted. (B) Increasing concentrations of the different proteins were added to a 1:9 
mixture of labeled (NBD-PE 1% and Rh-PE 1%) and unlabeled PG vesicles hydrated in medium 
buffer. (C) Increasing concentrations of the different proteins were added to PG vesicles loaded 
with ANTS and DPX. The %Fmax was calculated with respect the value obtained upon addition of 
0.5% Triton X-100. F. 
 
FIG 8. Hydrophobicity profile of preS-his (A) and mutants preS1-40 (B), preS20-60 (C), preS40-
80 (D), preS60-100 (E) and preS80-120 (F). The hydrophobicity index was calculated according to 
the scale proposed by Eisenberg [60]. 
 
FIG 9. Amino acid sequence of the preS domains of different HBV subtypes (A). Comparison of 
positions 47-66 of preS (ayw) with different retrovirus fusogenic peptides (B). The sequence 
GXF found in other fusogenic peptides is underlined. Sequence identities are shown in black 
boxes. 
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TABLES 
 
TABLE 1 Molecular mass and isoelectric point values of preS-his, preS1-40, preS20-60, preS40-
80, preS60-100 and preS80-120 
 
 preS-his preS1-40 preS20-60 preS40-80 preS60-100 preS80-120 
Mr (Da) 18055 13843 13760 14030 13984 13594 
pI 8.40 11.34 10.57 8.48 6.78 6.41 
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TABLE 2 Amino acid composition of preS-his, preS1-40, preS20-60, preS40-80, preS60-100 and 
preS80-120.  
 
aaa preS-his preS1-40 preS20-60 preS40-80 preS60-100 preS80-120 
Asx 21 (21) 10 (10) 12 (12) 18 (18) 19 (19) 18 (18) 
Thr 12-13 (14) 10 (11) 10 (11) 11 (12) 10(11) 7 (8) 
Ser 11-13 (14) 9-11 (12) 11-13 (14) 11-13 (14) 8(10) 8 (10) 
Glx 11 (11) 9 (9) 11(11) 8 (8) 6 (6) 6 (6) 
Pro 23 (23) 18 (18) 17 (17) 18 (18) 14 (14) 15 (15) 
Gly 16 (16) 14 (14) 12 (12) 8 (8) 11 (11) 15 (15) 
Ala 13 (13) 10 (10) 7 (7) 8 (8) 10 (10) 11 (11) 
Val 4 (4) 4 (4) 3 (3) 3 (3) 4 (4) 4 (4) 
Met 1 (2) 2 (2) 1 (2) 1 (2) 1 (2) 0(1) 
Ile 3 (3) 3 (3) 3 (3) 2 (2) 2 (2) 3 (3) 
Leu 15 (15) 12 (12) 14 (14) 10 (10) 10 (10) 12 (12) 
Tyr 1 (1) 1 (1) 1 (1) 1 (1) 1 (1) 1 (1) 
Phe 9 (9) 5 (5) 5 (5) 7 (7) 9 (9) 8 (8) 
His 10 (4+6) 9 (3+6) 9 (3+6) 9 (3+6) 10 (4+6) 8 (2+6) 
Lys 2 (2) 1 (1) 0 (0) 1 (1) 2 (2) 2 (2) 
Arg 7 (7) 6 (6) 6 (6) 7(7) 5 (5) 4 (4) 
Trp N.D.b (4) N.D. (3) N.D. (2) N.D. (2) N.D. (3) N.D. (3) 
 
a The values in parentheses correspond to the theoretical composition determined from the cDNA 
sequence. 
b N. D. (not determined). 
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TABLE 3 Secondary structure of preS-his and mutant proteins calculated from the CD spectra 
according to the CCA method [28] 
 
Protein 
Secondary Structure (%) 
α-helix β-sheet β-turn aperiodic 
 pH 7.0 pH5.0 pH 7.0 pH5.0 pH 7.0 pH5.0 pH 7.0 pH5.0 
preS-his 0 0 18 15 30 32 52 53 
preS1-40 0 0 12 12 34 36 54 52 
preS20-60 0 0 18 9 32 36 50 55 
preS40-80 0 0 18 11 30 30 52 59 
preS60-100 2 0 21 15 29 26 48 59 
preS80-120 3 0 17 17 28 26 52 57 
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TABLE 4 Fluorescence emission maxima and partition coefficients of the interaction of NBD-
preS-his, NBD-preS1-40, NBD-preS20-60, NBD-preS40-80, NBD-preS60-100 and NBD-preS80-120 
with PG vesicles. 
 
 
Protein pH PG Emission Maxima K (M
-1) x 10-4 
NBD-preS-his 7.0 532 0.3 ± 0.1 5.0 522 2.9 ± 0.7 
NBD-preS1-40 5.0 526 1.8 ± 0.5 
NBD-preS20-60 5.0 528 1.7 ± 0.2 
NBD-preS40-80 5.0 523 2.4 ± 0.5 
NBD-preS60-100 5.0 528 2.8 ± 0.7 
NBD-preS80-120 5.0 528 1.4 ± 0.8 
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TABLE 5 Secondary structure of preS-his and mutant proteins in the presence of PG at a 
protein/lipid molar ratio of 1:50 calculated from the CD spectra according to the CCA method 
[28]. 
 
Protein Secondary Structure (%) α-helix β-sheet β-turn aperiodic 
 pH 7.0 pH 5.0 pH 7.0 pH 5.0 pH 7.0 pH 5.0 pH 7.0 pH 5.0 
preS-his 16 17 6 40 30 8 48 35 
preS1-40 17 22 35 32 16 10 32 36 
preS20-60 24 23 0 26 27 10 49 41 
preS40-80 22 22 0 25 28 8 50 45 
preS60-100 18 22 5 30 23 7 54 41 
preS80-120 19 14 2 16 25 22 54 48 
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